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Foreword
Since the creation of the Centers for Disease Control and Prevention (CDC) in 1946, the agency's 
global health activities have expanded in scale, scope, and depth to address evolving health 
challenges and emerging threats around the world. From an early focus on malaria prevention and 
control in the United States, CDC's efforts have expanded globally over time to encompass diverse 
diseases and conditions, protect the United States from external health threats, improve public 
health capacity internationally, and acquire science-based knowledge to improve domestic as well 
as global health.
In 2010, CDC established its Center for Global Health (CGH), recognizing that domestic and global 
health are indivisible and tha t no country can protect the health of its citizens in isolation from the 
rest of the world.1 CDC engages internationally to protect the health of the American people and 
save lives worldwide, in the belief that healthy societies are also more just, stable, and prosperous.
CDC possesses unique expertise to address the challenges of global health and works in concert 
with domestic and international partners to improve health and well-being around the world. CGH 
is responsible for technical work conducted by global programs within the Center, including global 
immunization, HIV/AIDS, disease detection and response, health systems and laboratory 
strengthening, and parasitic diseases and malaria. Many other CDC programs contribute expertise 
and engage in global health work, including for tuberculosis elimination, the control of sexually- 
transm itted diseases and hepatitis infections, antimicrobial resistance, bacterial and viral 
respiratory infections, vectorborne diseases, rabies, and viral hemorrhagic fevers. CGH facilitates 
collaborations among these programs and in many cross-cutting areas such as maternal and child 
health, refugee health, infectious and non-communicable diseases, outbreak responsiveness, and 
w ater and sanitation. In addition, CGH provides leadership and management support to CDC's field 
staff and country offices, the agency's visible face on the front lines internationally where global 
health activities are implemented and country priorities are supported.
This global health strategy articulates CDC's role in global health, communicates the vision for 
global health work a t CDC, and identifies CDC's global health priorities. (See Appendix for a list of 
reference materials used in the development of the CDC Global Health Strategy.) Invaluable input 
and support from across the agency and from external partners were provided during the strategy 
development process. CDC staff reviewed program-specific strategies, conducted interviews with 
its Country Directors, and facilitated workshop discussions with over 100 CDC subject m atter 
experts. Staff solicited external feedback from representatives of key partners including the United 
States Agency for International Development (USAID), U.S. Department of State, Health and Human 
Services Office of Global Affairs, Department of Defense, United Nations Children's Fund (UNICEF), 
World Health Organization (WHO), CDC Foundation, and select ministries of health (MOHs). CDC 
also received guidance and direction from the Global Work Group, a sub-group of the Advisory 
Committee to the CDC Director, responsible for providing input on CDC global health issues.
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I sincerely thank all those who contributed to the development of this strategy. The world has 
changed enormously over the past decade and organizations m ust adapt to that change. The 
creation of CGH offers opportunities for CDC to increase programmatic impact in health 
internationally, to augment links and collaborations between CDC's domestic and global experts, 
and to strengthen overall global public health capacity. The strategy should be a living document, 
adapting as further challenges arise and reflecting the increasingly im portant role of CDC as a 
cornerstone of the world's public health infrastructure. Thank you to those who work every day to 
improve the health of our world.
Sincerely,
Kevin M. De Cock, MD, FRCP (UK), DTM&H
Director, Center for Global Health, Centers for Disease Control and Prevention 
June 29, 2012
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Executive Summary
The Centers for Disease Control and Prevention (CDC) is inspired by the vision of a world where 
people live healthier, safer, and longer lives. Achieving this vision requires that CDC continue to 
address current global health concerns while simultaneously investigating and responding to 
emerging risks. To m eet these combined challenges and achieve tangible, sustainable public health 
progress, CDC relies on its core strengths and strong partnerships. CDC's future successes in global 
health work are dependent upon efforts to leverage existing public health infrastructure and 
investments, develop and support country capacity in public health, and build upon the agency's 
standing as a trusted partner to shape global health strategy and policy based on sound science.
CDC builds its global health strategy on a foundation of 60 years of domestic and global public 
health leadership, expertise, and strong collaborations with ministries of health (MOHs), World 
Health Organization (WHO), U.S. Government agencies, and other critical partners. (See Appendix 
for a list of reference materials used in the development of the CDC Global Health Strategy.)
CDC addresses current and prepares for future challenges by leveraging its core strengths:
• Providing technical expertise.
• Implementing evidence-based public health programs.
• Developing surveillance and strategic information systems.
• T ranslating research into public health policy and practice.
• Building public health workforce capacity.
• Strengthening laboratory systems.
• Improving emergency preparedness and response capabilities.
• Conducting monitoring and evaluation activities to ensure health impact and cost- 
effectiveness.
CDC's Global Health Strategy for 2012-2015 includes four goals to be achieved between 2012 and 
2015: improved health impact, enhanced global health security, increased country public health 
capacity, and maximized organizational capability.
Goal 1: achieve health impact by improving the health and well-being of people around the world. 
To accomplish this, CDC focuses on
• Preventing new HIV infections and serving the needs of HIV-positive individuals globally.
• Reducing morbidity and mortality associated with tuberculosis and malaria.
• Reducing maternal and perinatal mortality.
• Reducing child morbidity and mortality.
• Eliminating and controlling targeted neglected tropical diseases (NTDs).
• Controlling, eliminating or eradicating vaccine-preventable diseases (VPDs).
• Reducing the burden of non-communicable diseases (NCDs).
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Since its creation, CDC has focused on improving health and preventing disease, w hether through 
leading research and laboratory activities or developing and implementing programs. To achieve 
health impact, the agency continues this approach in its engagement in a number of global and 
presidential initiatives that cover a range of priorities from disease-specific and population-based 
targets to improvements in health systems and policy.
Goal 2: improve capabilities to prepare for and respond to infectious diseases, other emerging 
health threats, and public health emergencies by
• Strengthening capacity to prepare for and detect infectious diseases and other emerging 
health threats.
• Responding to international public health emergencies and improving country response 
capabilities.
The health of Americans is integrally connected to the health of the rest of the world. Governments 
and organizations m ust work together to strengthen public health programs and increase the 
ability of countries to respond to and address disease threats on a global scale. Strengthening 
health security contributes to healthy, stable, and productive societies.
Goal 3: build country public health capacity as a means to achieve lasting health improvements.
The key areas for capacity building include
• Strengthening public health institutions and infrastructure.
• Improving surveillance and use of strategic information.
• Building workforce capacity.
• Strengthening laboratory systems and networks.
• Improving research capacity.
Building, strengthening, and maintaining countries' capacity to improve the health and well-being 
of their citizens is vital for sustainability. As countries are increasingly able to take responsibility 
for the programs and resources needed to maintain public health capacity locally, CDC assists with 
the transition of program ownership and leadership to MOHs and other local partners.
Goal 4: maximize potential of CDC's global programs to achieve impact by
• Strengthening organizational and technical capacity to better support CDC's global health 
activities.
• Enhancing communication to expand the impact of CDC's global health expertise.
CDC m ust function in an integrated way across multiple CDC programs for synergy, efficiency and 
coordination. CGH is key in fulfilling this goal, providing management and operational support to 
the agency's field staff and country offices and enhancing communication and coordination of global 
health activities across CDC.
CDC's Global Health Strategy outlines the agency's approach to achieving its global health vision. It 
will be integrated into planning, decision-making, and implementing and evaluating CDC's global
Centers for Disease Control and Prevention
Global Health Strategy
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health activities. CDC looks forward to working with its partners across the U.S. Government, 
international organizations, MOHs, civil society groups and partner countries as we continue to 
strive for lasting impact in global health.
Centers for Disease Control and Prevention
Global Health Strategy
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The Centers for Disease Control and Prevention (CDC) aspires to create a world where people 
live healthier, safer and longer lives. Achieving this vision will require that CDC address current 
pressing health concerns, in addition to meeting emerging global health needs. The agency will 
draw upon innovation and research to m eet these combined challenges and assure even greater 
health impact in the future. In addition, CDC and its partners will develop new evidence upon 
which tomorrow's improved health policies and programs will be based. Building upon 60 years of 
evidence-based domestic and global health work, CDC and partners m ust act together to protect 
Americans from health threats, save lives and prevent disease, and contribute to safer and more 
stable societies around the world. The agency's fundamental approach is to work in partnerships
to strengthen global health capacity, increase global health security, and achieve greater 
global health impact.
CDC's greatest global health assets are its staff in the United States and around the world and the 
tru st and credibility they have developed with partners and the public. CDC understands the 
importance of trust placed in the agency to improve health and prevent diseases. CDC also takes 
seriously its responsibility to be a good stew ard of resources provided to address the world's 
leading health issues. The foundation for CDC's global policy and programmatic decisions and 
engagement is technical rigor and expertise, special partnerships with ministries of health (MOHs) 
and multilateral organizations such as World Health Organization (WHO), an emphasis on capacity 
building and health impact from programs, and a commitment to science and evidence.
CDC's future successes in global health work are dependent upon efforts to leverage existing public 
health infrastructure, develop and support country capacity in public health, and build upon the 
agency's standing as a trusted partner to shape global health strategy and policy based on sound 
science.
Building on Existing Public Health Infrastructure
The nature of global health has evolved over time, requiring attention to new infectious disease 
challenges, potential bioterrorist activities, increasing antimicrobial resistance, new and diverse 
health threats from environmental and climate change, and the growing burden of non- 
communicable diseases (NCDs). CDC's longstanding partnerships with host countries, for example 
through its role as a partner in the President's Emergency Plan for AIDS Relief (PEPFAR), have 
created infrastructure that can serve as a foundation for deeper engagement, strategic 
collaboration, integrated health programming, and increased country ownership. PEPFAR is led by 
the Office of the Global AIDS Coordinator, Department of State, and leverages CDC's core 
competencies while bringing together all U.S. Government agencies under a whole-of-government 
approach. Through PEPFAR, CDC has worked with countries to build laboratory networks, improve 
surveillance capabilities, create health information systems, develop service delivery models, and 
strengthen workforce capacity. This infrastructure can serve as a foundation for maximizing 
investments and enhancing CDC's ability to address other public health issues.
CDC Global Health Vision
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Strengthening Country Public Health Capacity
CDC builds country capacity by sharing its expertise in developing, translating, and adapting 
scientific evidence into policies and program implementation. Efforts by CDC and its partners to 
increase countries' capacities to implement and evaluate their own public health activities will 
reduce the need for direct U.S. support and increase country ownership and sustainability of public 
health programs. In addition, when partner countries have stronger public health detection and 
response capacities, the United States is less likely to be threatened by the global spread of disease. 
Similar to the experience working with state health departm ents in the United States, CDC 
anticipates that its relationships with partner MOHs will change as the countries' public health 
expertise and capacity increase. CDC's role will evolve from support of direct services to engaging 
as a technical advisor to MOHs.
Shaping the Global Health Agenda in Collaboration with Partners
CDC plays a prom inent role in shaping the future global health agenda through engagement with 
partners, serving as a key contributor to development of guidelines and strategies, and effectively 
delivering public health programs on a bilateral as well as multilateral basis. Multilateral 
involvement through such mechanisms as deployment of staff and allocation of resources shape 
global, regional and country-level public health policy and goals; influence global, regional and 
country-level program implementation; provide leadership and support for global laboratory 
networks; and contribute to global public health research and innovation. Guided by science and 
impact, CDC will continue to provide worldwide technical assistance for both the unfinished 
business of infectious diseases and the evolving challenges of non-communicable diseases. CDC will 
build strategic relationships tha t efficiently leverage the unique roles of all of its partners.
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CDC's global health mission is to protect and improve health globally through science, policy, 
partnership, and evidence-based public health action. The motivation for CDC to work in global 
health is to protect the people of the United States, prevent disease, save lives worldwide, and 
contribute to stable, productive societies. CDC achieves its global health mission by leveraging its 
core technical strengths and partnerships. The agency's respected capacity to respond to disease 
outbreaks and other public health emergencies, as well as its placement of staff in country offices, 
often results in CDC being on the scene early in events of public health concern. CDC strives not only 
to implement programs around the world to improve health, but also to build sustainable country 
public health capacity to address health issues. Through research and science-based programs, CDC 
works towards increasing global health capacity, assuring global health security and achieving 
measurable global health impact for safer, healthier and longer lives worldwide. The following list 
describes the guiding principles for CDC's global health work.
CDC Global Health Mission
Guiding Principles for CDC's Global Health Work
• Provide technical leadership and guidance to inform and develop strategies and policies to address 
global health issues.
• Develop and use data from proven scientific research findings to drive public health action.
• Strengthen the ability of countries to achieve improved global health outcomes.
• Provide leadership to develop and implement approaches to eradicate and eliminate disease.
• Promote equal access and delivery of public health interventions.
• Maximize global health impact through coordination, program integration, and partnerships.
• Monitor and evaluate programs to measure health impact and ensure cost effectiveness.
CDC Core Technical Strengths
CDC provides technical leadership on topics from specific diseases and general health issues, to 
more cross-cutting systems and organizational 
capacity issues. In these areas, CDC fills a unique role 
in relation to other U.S. Government (USG) and 
international agencies and non-governmental 
organizations (NGOs). Broadly, CDC has unique 
capacity in areas of health systems strengthening, 
such as disease surveillance and health information 
systems (including monitoring and evaluation), 
public health laboratory capacity, workforce training, 
operational research and public health actions an d  
programs (See Figure 1). In addition, the agency has 
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specific areas, implementation and evaluation of specific public health programs, and provision of 
technical assistance to MOHs, other public health institutions, and NGOs. An overview of CDC's core 
technical strengths is described below.
Providing Technical Expertise
CDC has over 300 employees deployed full-time in more than 55 countries around the world, and 
approximately 1,400 host country national staff providing crucial support and technical assistance 
to host country programs. Of the long-term CDC staff deployed internationally, m ost are located in 
CDC country offices. Approximately 10% are detailed to international organizations such as WHO 
and the United Nations Children's Fund (UNICEF), providing counsel, training, and technical 
assistance, while acquiring valuable knowledge and experience to inform current and future 
programs. In addition, CDC draws upon the extensive knowledge and skills of its headquarters' 
subject m atter experts to provide technical assistance in global work. In FY 2011, CDC sent 2,136 
public health professionals on 5,634 temporary duty missions to 156 countries around the world.
Im plem enting Evidence-Based Public Health Programs
In collaboration with MOHs and other partners, CDC provides the evidence-base for supporting 
program implementation and public health action. W hether focused on infectious or non- 
communicable diseases, emergency preparedness and response, or environmental health, CDC's 
special value results from the synergy of its different technical strengths. CDC works alongside host 
country staff to plan, implement and evaluate comprehensive public health programs across 
diseases to achieve maximum, cost-effective public health impact.
D eveloping Surveillance and Strategic 
Inform ation System s
A core strength for CDC is its ability to develop, 
strengthen, and evaluate surveillance and 
strategic information systems. The agency is 
committed to helping MOHs build the capacity to 
collect the health information needed to make 
sound decisions for appropriate use of limited 
resources, respond to public health problems, and 
assess the impact of interventions. These data 
systems provide a solid basis for decision-making 
for targeting and implementing programs with 
maximum effect.
Translating R esearch into Public Health 
Policy and Practice
CDC conducts and supports research to influence public health policy and practice in addressing 
global health challenges. This research includes evaluating existing interventions and programs as 
well as developing and assessing new tools, strategies, and interventions tha t can then be 
implemented and brought to scale, or used to modify existing programs for greater impact.
Centers for Disease Control and Prevention
Global Health Strategy
CDC Core Technical Strengths
• Providing technical expertise
• Implementing evidence-based public 
health programs
• Developing surveillance and strategic 
information systems
• Translating research into public 
health policy and practice
• Building public health workforce 
capacity
• Strengthening laboratory systems
• Improving emergency preparedness 
and response capabilities
• Conducting monitoring and 
evaluation
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Building Public Health W orkforce Capacity
With a skilled and competent workforce, countries are better equipped to quickly identify and 
respond to public health challenges and threats. Provision of training and technical leadership to 
build an effective in-country public health workforce in epidemiology, laboratory sciences, disease 
prevention, management, and leadership is a fundamental function for CDC in global health.
Strengthening Laboratory System s
Frequently consulted from around the world, CDC plays an im portant role in global health 
laboratory work and often serves as a global reference laboratory. At country level, CDC works to 
strengthen national, regional, and local laboratories and ensure their diagnostic capacity and 
appropriate specimen-handling, quality assurance systems, and adequate biosafety standards. As a 
result of CDC's efforts, many laboratories around the world are better able to detect and monitor 
diseases of public health importance. These laboratory strengthening efforts are an essential 
component of promoting health security globally and protecting the U.S. population by 
identification and control of key diseases at their source.
Im proving Em ergency Preparedness and R esponse Capabilities
Ensuring emergency preparedness and response capability is the responsibility of national MOHs 
and international organizations such as WHO. An im portant element of readiness and response 
capability that CDC actively supports is implementation of and compliance with the International 
Health Regulations (IHRs), which the agency helped to define and establish. CDC also supports 
global readiness through its health systems strengthening work and frequent direct participation in 
public health responses to disease outbreaks, natural disasters, and other emergencies. CDC often 
delivers onsite technical support and training for data collection and analysis, providing the basis 
for effective response to health threats and public health emergencies.
Conducting M onitoring and Evaluation Activities
CDC's monitoring and evaluation activities include tracking program progress and impact, building 
partners' m easurement capacities, and correcting and improving programs using evidence 
collected. CDC uses data to determine the effectiveness of programs, interventions, and policies. The 
agency uses its expertise in the monitoring and evaluation of public health programs across a wide 
range of disciplines and countries.
Partnerships
The scope and intensity of global health challenges ensure that no single country or agency can 
work alone to m eet them. Partnerships are a cornerstone of CDC's global health work. To contribute 
to shared global health objectives, CDC works in close partnership with a wide array of 
international agencies and institutions to shape global health policies and to fund, implement, and 
evaluate programs. CDC's partnerships with international and multinational organizations include 
WHO and its regional offices, other United Nations agencies (such as UNICEF), and affiliated 
agencies such as the United Nations Foundation, the World Bank, private foundations, universities, 
and global health organizations. Within the U.S. Government, CDC partners with the United States 
Agency for International Development (USAID), including its Prevent Malaria Initiative (PMI); the 
Department of State's Offices of the Global AIDS Coordinator and the Global Health Initiative; U.S.
Centers for Disease Control and Prevention
Global Health Strategy
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embassies; HHS Office of Global Affairs; the Department of Defense; the Peace Corps; and other USG 
agencies to implement the U.S. Government's global health agenda. CDC engages across these 
agencies and offices, building on the individual strengths of each, for a comprehensive, 
complementary, whole-of-government approach to global health.
One of CDC's principal partners in global health is MOHs. CDC staff assigned in countries, embedded 
in MOHs, and deployed from the United States, provide technical expertise, mentoring, and broad 
support to build national and regional capacity. These partnerships not only provide technical 
knowledge from CDC to partners, bu t also create opportunities for CDC to learn from partners and 
communities. CDC recognizes the central role played by MOHs and understands tha t long-term 
sustainability for in-country health activities is contingent on MOH programmatic and management 
capacity to plan, implement, monitor, and evaluate programs. CDC responds to MOH requests to 
assist with the investigation and containment of infectious disease outbreaks and other health 
threats, but places special emphasis on development of long-term capacity. CDC assistance to build 
sustainable public health capacity requires interdisciplinary collaboration between clinicians, 
epidemiologists, laboratory scientists, veterinarians, health educators, and other scientists and 
program managers. CDC collaborates with countries interested in developing their own national 
public health institutes and prioritizes its work in workforce development. In this regard, CDC's 
interactions with MOHs are reminiscent of experience in the United States with individual states 
where direct engagement and program implementation evolved into a relationship based on 
technical assistance and partnership.
Centers for Disease Control and Prevention
Global Health Strategy
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CDC's global health strategy builds on the agency's many years of programmatic experience and 
accomplishments in implementing effective public health programs.
CDC Global Health Strategy
The strategy is characterized by four overarching goals and 17 objectives which capture the major 
areas of programmatic focus for CDC, including CGH's role of coordinating global health activities. 
The following table displays how the objectives align to the goals.
Goal Objectives
1.Health Impact: improve the 
health and well-being of people 
around the world
• Prevent new HIV infections and serve the needs of HIV- 
positive individuals globally
• Reduce tuberculosis morbidity and mortality
• Reduce malaria morbidity and mortality
• Reduce maternal and perinatal mortality
• Reduce child morbidity and mortality
• Eliminate and control targeted neglected tropical diseases 
(NTDs)
• Control, eliminate, or eradicate vaccine-preventable diseases 
(VPD)
• Reduce burden of NCDs
2.Health Security: improve 
capabilities to prepare and 
respond to infectious diseases, 
other emerging health threats, 
and public health emergencies
• Strengthen capacity to prepare for and detect infectious 
diseases and other emerging health threats
• Respond to international public health emergencies and 
improve country response capabilities
3.Health Capacity: build country 
public health capacity
• Strengthen public health institutions and infrastructure
• Improve surveillance and use of strategic information
• Build workforce capacity
• Strengthen laboratory systems and networks
• Improve research capacity
4.Organizational Capacity:
maximize potential of CDC's 
global programs to achieve 
impact
• Strengthen organizational and technical capacity to better 
support CDC's global health activities
• Enhance communication to expand the impact of CDC's 
global health expertise
Priorities have been established for each objective, and those priorities include major public health 
areas where substantial progress can be made with sustained, coordinated effort. These priorities 
align to CDC's Winnable Battles, which are 1) reduced mother-to-child HIV transmission and
14
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congenital syphilis; 2) enhanced coverage and impact through global vaccination initiatives, 
including against polio; 3) elimination of lymphatic filariasis and NTDs in the Americas; 4) reduced 
tobacco use; and 5) decreased motor vehicle injuries. These areas have been identified as 
opportunities for intervention because of the availability of practical, evidence-based strategies, 
and the potential for measuring progress across a large proportion of persons at greatest risk.
Furthermore, the CDC Global Health Strategy is built upon and supports the goals and objectives 
identified in the Global Health Strategy of the U.S. Department of Health and Human Services 
(2012-2015) and in other major global health strategies. (See Appendix for a list of reference 
materials used in the development of the CDC Global Health Strategy.)
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Goal 1: Health Impact: Improve the Health and Well-being of 
People around the World
Since its creation, CDC has focused on improving health and preventing disease. W hether through 
leading research and laboratory activities or developing and implementing programs, CDC 
leverages the technical expertise of its workforce a t headquarters and in the field to achieve 
improvement and build the capacity of its in-country partners.
CDC engages in a number of global and presidential initiatives that cover a range of priorities, from 
disease-specific and population-based targets to health systems and policy. Examples of strategies 
and initiatives used to inform the development of the CDC Global Health Strategy include the HHS 
Global Health Strategy, Global Health Initiative, Millennium Development Goals, President's Malaria 
Initiative, PEPFAR, and others. By aligning with these initiatives, CDC is better positioned to 
improve health and prevent disease among people both in the United States and around the world.
Objective 1.1: Prevent New HIV Infections and Serve the Needs of HIV 
Positive Individuals Globally
PEPFAR has achieved remarkable progress since its launch in 2003. PEPFAR is led by the Office of 
the Global AIDS Coordinator, Department of State, and brings together different USG agencies to 
create a whole-of-government approach and leverages CDC's core strengths. CDC is an essential 
PEPFAR partner and is integral to the success of this program. There are now over 3.9 million 
people living with HIV who are receiving antiretroviral treatm ent (ART) through USG support,3 and 
global ART coverage has risen to 47% in 2010.4 This achievement is due in large part to 
increasingly cost-effective program implementation, which has driven down the average cost of 
ART (see Figure 2).6 Services for prevention of mother-to-child transmission of HIV (PMTCT) have 
also expanded dramatically with global coverage 
currently a t 48% of eligible pregnant women in 
2010.7 Due to PEPFAR investments, 
approximately 200,000 infants were born HIV- 
free in FY 2011.8 Key progress has also been 
achieved in HIV prevention; care and support of 
HIV-infected persons; workforce capacity; 
maternal and child health; surveillance, 
epidemiology, laboratory and health information systems; program monitoring and evaluation; and 
operational research. In addition, CDC leverages partnerships with international organizations such 
as WHO; the Global Fund to Fight AIDS, Tuberculosis and Malaria; Joint UN Programme on 
HIV/AIDS (UNAIDS); UNICEF; the World Bank and others to maximize public health improvement.
In 2011, PEPFAR saved approximately 7.7 
million life years through antiretroviral 
treatment. Since 2004, approximately 
585,000 infants have been born HIV-free 
through PEPFAR-supported PMTCT 
services.5
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Despite tremendous progress,
HIV/AIDS is still among the leading 
causes of death globally, with more than 
4,900 deaths every day and an 
estimated 2.7 million new HIV 
infections in 2010.7 However, recent 
advancements in HIV/AIDS research 
have dem onstrated that several 
prevention interventions, including 
ART, are highly efficacious in halting the 
transmission of HIV. Building on these 
scientific findings, President Obama and 
Secretary of State Clinton announced in 
2011 tha t the U.S. Government would 
commit to expanding the provision of 
proven prevention interventions to achieve the goal of creating an AIDS-free generation.9 
Specifically, the Secretary of State outlined a new USG strategy for PEPFAR emphasizing expanded 
ART, PMTCT and voluntary medical male circumcision, as well as increased provision of HIV 
counseling and testing services and continuing support for correct and consistent condom use. The 
goal of an AIDS-free generation was defined as a future in which virtually no children are born with 
HIV and individuals live successfully with HIV due to early, sustained treatm ent.10 The goal also 
includes dramatically reduced HIV transmission by expanding prevention interventions with 
proven efficacy. On World AIDS Day 2011, President Obama committed the U.S. Government to 
support 6 million HIV-positive individuals on ART, 1.5 million additional HIV-positive pregnant 
women on antiretroviral medications for PMTCT and 4.7 million men voluntarily circumcised by 
the end of 2013.11
CDC Strategic Priorities
• Reduce HIV incidence and achieve an AIDS-free generation through expanded service 
delivery in the highest-burden countries focusing on HIV care and treatment, PMTCT, 
voluntary medical male circumcision, and HIV counseling and testing services.
• Measure impact and health outcomes by monitoring and evaluating CDC-supported direct 
service delivery programs to ensure quality, efficiency and progress against annual targets.
• Determine the ideal balance of prevention interventions and levels of coverage needed to 
achieve reductions in HIV incidence by monitoring and evaluating “combination 
prevention” implementation.
• Conduct research to determine the most efficacious and cost-effective interventions and 
regimens for HIV prevention, care and treatment.
• Strengthen country capacity to implement HIV/AIDS programs by improving MOH 
leadership and management capabilities and by strengthening capabilities in surveillance, 
epidemiology, laboratory, workforce, health information systems and program monitoring 
and evaluation with the goal of carefully transitioning programmatic and financial 
responsibilities to host governments and local partners over time.
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Note: P er-patientbudget allocaton is estim ated  as lagged trea tm ent allocatoli divided b y  end-of-reporting direct patients.
Figure 2: PEPFAR ART Average Cost and Direct ART Patients Over 
Time
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Objective1.2: Reduce Tuberculosis Morbidity and Mortality
One-third of the world's population is infected with tuberculosis (TB) and each year, nearly nine 
million people become sick with TB resulting in an estimated 1.5 million deaths worldwide.12 WHO 
estimates that in 2010, there were 10 million children orphaned by TB worldwide.12TB is an issue 
of global concern and a major focus for prevention and control efforts for CDC and partners 
throughout the world. The Global Plan to Stop TB 2011-2015 has established a goal of 50% 
reduction in TB prevalence and death rates by 2015, compared with 1990 levels. CDC contributes to 
the achievement of these goals by working to improve the quality of TB control programs 
internationally in countries with a high burden of TB and those that contribute significantly to TB 
burden in the United States. CDC provides critical technical support to international partners for 
epidemiology and surveillance (including for drug-resistant TB); laboratory strengthening; clinical 
and operational research tha t evaluates promising diagnostic, treatm ent and prevention strategies. 
CDC is currently engaged in activities to promote the scale-up of the “three Is” (intensified case 
finding, isoniazid preventive therapy, and infection control) and early initiation of ART for people 
living with HIV in low resource countries with TB/HIV syndemics.
CDC's global TB control activities are mainly conducted in high-burden countries and countries of 
origin for foreign-born US TB cases, working with MOHs and other partners to build strong national 
TB programs. CDC plays an im portant role in 
finding the most effective ways to implement new 
tools and approaches in resource-limited and 
high-burden settings through clinical and 
operational research, technical assistance, 
program and policy design, demonstration 
projects, and program monitoring and evaluation.
CDC focuses on supporting innovative approaches
to screening, diagnosis, case-finding, and curing TB to stop the spread of disease and prevent 
development of drug resistance, and provides technical support and builds capacity for 
implementation of TB treatm ent programs, (e.g., DOTS).
CDC Strategic Priorities
• Conduct programmatically relevant research that informs and strengthens TB programs' 
ability to achieve global TB prevalence and mortality targets.
• Support the implementation of evidence-based TB activities through technical guidance, 
training, and piloting new tools and approaches in designated countries.
• Improve prevention and control of TB through enhanced technical assistance and by 
emphasizing the use of existing effective strategies (e.g., DOTS) and new tools.
• Strengthen TB surveillance including anti-TB drug resistance surveillance and impact 
m easurem ent by providing scientific leadership and direct technical assistance to selected 
countries.
• Improve TB detection, control and management by conducting clinical and laboratory 
research aimed at developing and testing new tools for TB control, including shorter, 
effective treatm ent and prevention regimens and better diagnostic tests.
Centers for Disease Control and Prevention
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CDC's strategic TB research has yielded two 
groundbreaking findings identifying better 
ways to prevent and diagnose TB in people 
living with HIV (PLHIV). These studies 
changed international guidelines and are 
now being scaled up around the world.13
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• Build global human resource capacity for TB prevention and control through training, 
conducting collaborative research, and providing technical assistance to high-burden and 
origin countries.
Objective 1.3: Reduce Malaria Morbidity and Mortality
Approximately half the world's population lives in areas at risk of malaria transmission. WHO 
estimates that in 2010 malaria caused approximately 216 million clinical episodes and 655,000 
deaths. Of these malaria deaths, 86% were children under 5 years of age, and 91% occurred in sub- 
Saharan Africa.14 CDC provides scientific leadership in the fight against malaria through technical 
expertise in policy development, program guidance 
and support, scientific research, and monitoring and 
evaluation of progress tow ard Roll Back Malaria 
goals. Together with USAID, CDC implements the 
President's Malaria Initiative (PMI), which was first 
established in 2006.
The goal of PMI is to reduce malaria-related deaths 
by 50% in PMI-focus countries and regions with a 
high burden of malaria by expanding coverage of four highly effective malaria prevention and 
treatm ent measures: insecticide treated bed nets (ITNs), indoor residual spraying (IRS), 
interm ittent preventive treatm ent during pregnancy (IPTp), and artemisinin combination therapy 
(ACT). CDC-led science has established the efficacy and potential impact of each of these 
recommended interventions.16 Through PMI and its partners since 2006, tens of millions of 
persons have received long-lasting ITNs or had their residences treated with IRS. Case management 
training for tens of thousands of health workers and the distribution of rapid diagnostic tests has 
resulted in better case management. PMI procured more than 41 million ACT treatm ents and 6 
million IPTp treatm ents in 2010 alone. 17
CDC provides technical expertise to improve vector control, case management, surveillance, 
monitoring and evaluation, and capacity building. CDC also works with MOHs and other partners to 
conduct essential operational research to optimize current interventions and develop new tools 
and strategies in the face of looming anti-malarial drug and insecticide resistance. CDC develops 
opportunities for integration of malaria prevention with other health and development initiatives.
In addition, the agency conducts activities to prevent, treat, and monitor malaria among U.S. 
travelers and visitors.
CDC laboratories have also been pivotal to WHO's call for universal access to high-quality malaria 
diagnosis and treatm ent for malaria illness. The agency performs quality testing of all commercially 
available malaria rapid diagnostic tests, an activity which is critical to procurem ent decisions by 
national and international authorities. CDC also participates in a global network to identify 
counterfeit and substandard treatm ent drugs.
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CDC has led the implementation of 
monitoring and evaluation activities in 
support of PMI in 17 countries. PMI 
data have shown a 16 to 50 percent 
reduction in all-cause mortality in 
children under five years since PMI 
activities began.15
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CDC Strategic Priorities
• Provide leadership in achieving global malaria reduction goals by providing technical 
expertise and guidance on operational research priorities and by supporting the 
implementation of malaria-related activities in designated countries.
• Promote an integrated and sustainable approach to malaria prevention and control by 
emphasizing the use of existing and new tools endorsed by WHO and local partners.
• Strengthen antimalarial drug-resistance surveillance and insecticide resistance monitoring 
programs by providing scientific leadership and enhanced laboratory support.
• Improve prevention and control of malaria through the development and testing of 
innovative methods and tools.
• Build global capacity for malaria prevention and control through training qualified 
malariologists, entomologists, and laboratory scientists and conducting collaborative 
research with and providing direct technical assistance to endemic countries.
Objective 1.4: Reduce Maternal and Perinatal Mortality
Progress is being made in reducing maternal and perinatal mortality; nevertheless, many countries 
still have maternal mortality ratios greater than 500 deaths per 100,000 live births.CDC is working 
with MOHs and other partners to impact positively the health of expectant and new mothers in a 
variety of ways, such as direct technical assistance to improve programs and technical expertise to 
improve the underlying health systems which women must use to manage their pregnancy.
CDC's current maternal and perinatal health 
activities can be broadly divided into two types 
of efforts: 1) technical assistance and evaluation 
of public health and clinical interventions 
focused on family planning, micronutrient 
fortification, integrated antenatal care 
(incorporating hand washing education with HIV 
and syphilis screening), and improved 
emergency obstetric and neonatal care (EmONC) 
services; and 2) technical guidance for health 
system strengthening activities with a focus on 
key information systems, including surveillance 
(maternal death surveillance and response), vital 
registration, birth registers, Reproductive Age 
Mortality Surveys, and routine program 
monitoring and evaluation.
CDC and its partners have contributed to implementing reproductive health surveys and 
developing guidelines for maternal death surveillance, family planning, and micronutrients. CDC 
supports strengthening district health system networks to improve access and quality of 
emergency obstetric and neonatal care. In addition, the agency contributes to the campaigns to 
eliminate congenital syphilis (monitoring, evaluation, and rapid testing strategies), perinatal 
hepatitis B transmission, and tetanus and to decrease neural tube defects through folic acid
CDC led the way in establishing that 
periconceptional use of 400 ^g of folic acid 
prevents neural tube defects. Mandatory 
folic acid fortification of cereal grain 
products in the USA contributed to a 36% 
reduction in neural tube defects. With 
CDC support through the Flour 
Fortification initiative, 63 countries have 
implemented policies fortifying foods with 
folic acid preventing at least 22,000 fatal or 
disabling birth defects annually world­
wide.18,19
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fortification. Given the importance of maternal and perinatal health in the global health arena, CDC 
is working to strengthen and expand its contributions to the achievement of USG and global goals.
CDC Strategic Priorities
• Provide leadership on measuring maternal mortality, understanding its causes and 
contributory factors, and accelerating effective responses to reduce maternal deaths by 
providing technical expertise and guidance on maternal death surveillance and response 
and functioning vital registration systems.
• Strengthen district obstetric care networks to improve coverage, access to and quality of 
emergency obstetric and neonatal care by supporting the development and implementation 
of technical guidelines, training of health care personnel, and development of information 
systems and monitoring and evaluation.
• Improve maternal and perinatal health interventions, particularly PMTCT and elimination 
of congenital syphilis, by strengthening coverage and quality of antenatal care services, 
diagnostic testing, and improving monitoring and evaluation through better information 
systems.
• Increase contraceptive prevalence through integration of family planning with other public 
health programs and research to improve the uptake of long-acting reversible 
contraception.
• Expand m icronutrient supplementation and fortification to reduce neural tube defects and 
other conditions such as anemia through technical assistance, surveillance, and capitalizing 
on private partnerships.
Objective 1.5: Reduce Child Morbidity and Mortality
Children represent the future generations and growth of societies, and ensuring their healthy 
growth and development are of param ount concern. In 2010, an estimated 7.6 million children died 
before reaching their fifth birthday, a decrease of 
around 2 million childhood deaths during the past 
decade.20 Approximately 68% of these deaths are 
attributable to infectious diseases, most notably 
pneumonia (18% of deaths) and diarrhea (15% of 
deaths). Malaria, neonatal sepsis, HIV/AIDS, and 
measles are also im portant causes of death.
Undernutrition, including deficiencies of 
micronutrients such as vitamin A, iron, and zinc, 
contributes to at least one-third of all childhood 
deaths, usually in interaction with infectious 
causes.21 The vast majority of gains in child survival 
during the past decade have been accomplished 
through scale up of interventions such as 
immunization, m icronutrient supplementation,
access to safe water, insecticide-treated bednets (ITN), oral rehydration therapy, antibiotics, 
antimalarial therapy, and antiretroviral therapies.25Increased financial resources, strong
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Diarrheal diseases in children: over the 
past 5 years, CDC has provided 
technical support to partners that have 
resulted in the distribution of sufficient 
water treatment products to treat 12 to 
18 billion liters of water a year in over 
20 countries; water treatment can 
reduce the risk of diarrhea by 40%. CDC 
has also pioneered programs to 
integrate water treatment and hygiene 
into antenatal care, infant 
immunization visits, MCH clinics, and 
HIV services.22,23,24
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partnerships, intensified country support, innovations in service delivery approaches, 
improvements in women's education, and economic growth have made possible the gains in child 
survival during the past decade.
CDC has contributed to improvements in child health through its work on the WHO-UNICEF Global 
Action Plan for the Prevention and Control of Pneumonia (GAPP) that outlines specific goals and 
targets for pneumonia (vaccination and treatment). CDC is also a partner in the Global Cookstove 
Alliance, which aims to reduce pneumonia in women and children and increase birth weights 
through the use of clean cookstoves. CDC participates in key global partnerships in the fight against 
diarrheal disease, including the new WHO-UNICEF Diarrheal Disease Prevention and Control 
Strategy, which outlines seven key actions to reduce deaths in children. CDC contributes to 
improved child nutrition through m icronutrient supplementation and fortification programs. CDC 
strengthens public health systems with a focus on key information systems for child health 
including surveillance (birth defects, nutrition), vital registration, periodic surveys, routine 
program monitoring and evaluation, and capacity building.
Achievement of other health impact objectives in this strategy, including those around vaccine- 
preventable diseases, malaria, HIV/AIDS, and TB, assists with the achievement of this 
comprehensive child health objective. Looking a t ways to synergize, particularly in health systems 
strengthening, is key, and CDC collaborates closely with USG partners, particularly USAID, MOHs 
and others in this effort.
CDC Strategic Priorities
• Reduce respiratory disease deaths by supporting implementation and monitoring of the 
GAPP and Global Alliance for Clean Cookstoves to improve indoor air quality.
• Reduce diarrheal disease deaths by supporting implementation and monitoring of the 
WHO-UNICEF Diarrheal Disease Prevention and Control Strategy.
• Improve prevention and control of malnutrition with an emphasis on micronutrient 
deficiencies, breastfeeding, improved infant and young child feeding practices, and routine 
growth monitoring through technical assistance and support for the Flour Fortification 
Initiative.
• Improve care of sick infants and children, including diagnosis and management of sepsis 
and other severe infections in neonates, and diagnosis and management of infants and 
children with fever, pneumonia, diarrhea, and sickle cell disease.
• Strengthen child health information systems with a focus on monitoring and evaluation of 
child health programs, disease and nutrition surveillance, vital registration, and periodic 
surveys.
• Conduct research to better define the etiology of disease among infants and children and 
assess the effectiveness of prevention strategies that might reduce childhood morbidity and 
mortality.
Centers for Disease Control and Prevention
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Objective 1.6: Eliminate and Control Targeted Neglected Tropical 
Diseases
More than one billion people suffer from one or more neglected tropical diseases (NTDs).26 These 
NTDs are a group of infectious diseases that are the source of tremendous suffering because of their 
disfiguring, debilitating, and sometimes deadly impact. Many diseases have been grouped under the 
rubric of NTDs, including dengue, guinea-worm, rabies, and yaws. Five of the NTDs have been 
targeted by USG efforts, including the Global Health Initiative, CDC, and other global programs: 
lymphatic filariasis (LF), onchocerciasis, schistosomiasis, trachoma, and soil-transmitted helminths 
(STH).27’28’29 These NTDs are controlled by 
preventive chemotherapy. CDC helps inform 
global policy and guidelines for NTD control 
programs and conducts research to improve 
diagnostic and other tools needed to monitor 
programs. CDC scientists provide technical 
assistance to countries and partners to build 
capacity, improve programs, and monitor and 
evaluate progress towards elimination or control 
of NTDs.
CDC helps draft WHO guidelines that countries will use to assess progress of initiatives. For 
example, the Transmission Assessment Survey for LF is being used to determine when transmission 
of LF has been interrupted and mass drug administration (MDA) can be stopped. Early studies 
conducted by CDC and partners dem onstrated that mass treatm ent with drugs is a safe and 
effective way to control and potentially eliminate LF .30 More recently, CDC researchers 
dem onstrated that LF health education campaigns and morbidity control programs in India can 
increase adherence with MDA for LF by as much as 40%.31
CDC Strategic Priorities
• Reduce prevalence of five NTDs (LF, onchocerciasis, schistosomiasis, trachoma, and STHs), 
with a focus on program monitoring and evaluation.
• Contribute to the elimination of LF in Haiti and the Americas by implementing MDA in Port 
au Prince, Haiti.
• Reduce or eliminate NTDs through development, testing, and implementation of improved 
evidence-based diagnostic and epidemiologic tools.
• Conduct evaluation of integrated NTD programs to assess additional positive health 
outcomes beyond those associated with the targeted NTDs.
Objective 1.7: Control, Eliminate, or Eradicate Vaccine-Preventable 
Diseases
The burden of vaccine-preventable diseases (VPDs) in the United States has been greatly reduced 
due to childhood immunization. However, in an era of mass travel and global epidemics, the health 
of U.S. citizens is closely linked to disease occurrence in other countries. CDC's support for 
immunization programs worldwide contributes towards providing protection for the United States,
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CDC has contributed substantially toward 
elimination of onchocerciasis in the 
Americas: of the 13 original endemic foci, 
only 2 still have ongoing transmission. Scale 
up of efforts to eliminate lymphatic filariasis 
in Haiti has progressed through CDC 
leadership, including implementation of 
countrywide mass drug administration for 
the first time in 2011-12.
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as well as fulfilling the U.S. Government's broader commitment to global health. Immunizations are 
estimated to prevent more than 2.5 million child deaths annually around the globe, primarily due to 
the prevention of measles, diphtheria, polio, pertussis, and tetanus.32 Vaccination of children is also 
expected to reduce mortality in adults by preventing hepatitis B virus-related cirrhosis and liver 
cancer and human papillomavirus-related cervical cancer.33
Since the Global Polio Eradication Initiative (GPEI) began in 1988, the number of polio cases around 
the world has been reduced by >99% from over 350,000 cases per year to 650 cases in 2011.34 
Transmission of wild poliovirus (WPV) type 2, 
one of the three poliovirus serotypes, has been 
eliminated since 1999.36 However, new WPV 
cases increased substantially during 2011 in 
the three remaining polio-endemic countries 
(Afghanistan, Nigeria, and Pakistan), and 
international spread from polio endemic 
countries caused 11 WPV outbreaks globally, 
underscoring the risk WPV poses to all 
children, no m atter where they live.37 In 
January 2012, the completion of polio 
eradication was declared a “programmatic emergency for global public health” by the executive 
board of WHO. In response to this emergency, GPEI has developed the Global Polio Emergency 
Action Plan 2012-13. As a key GPEI partner, CDC has provided critical technical and financial 
support for polio immunization activities to interrupt WPV transmission, to maintain and enhance 
laboratory surveillance for polioviruses, to monitor progress towards reaching epidemiological 
targets, and to support development and implementation of a polio eradication research agenda 
with the long-term aim of stopping all global use of oral polio vaccine. In addition, CDC's Emergency 
Operations Center has been activated since December 2011 to support the final push for polio 
eradication.
Endemic measles and rubella have been eliminated from the W estern Hemisphere. To sustain and 
build on this achievement, CDC is working to control and eliminate measles and rubella in parts of 
the world responsible for importations into the United States. CDC is a founding member of the 
Measles and Rubella Initiative, which supports vaccination campaigns worldwide and has helped 
cut measles deaths globally by 74% from an estimated 535,000 deaths in 2000 to 345,000 deaths in 
2005, and to 139,300 deaths in 20 1 0.38 The Initiative's goals are now to further reduce measles 
deaths globally by 95% compared to measles deaths in 2000 and to eliminate measles and rubella 
in at least five of six WHO regions by 2020.
CDC also provides technical expertise to strengthen the performance of national immunization 
programs, strengthen national and global VPD surveillance systems, inform policy development and 
governance, and introduce new and expand underutilized vaccinations. CDC's efforts aim to protect 
each new birth cohort of approximately 130 million infants born around the world each year from 
VPDs. These efforts require well-functioning and accessible immunization delivery strategies, 
laboratory-based VPD surveillance systems, and high-quality research providing evidence to
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Since the Global Polio Eradication Initiative 
was started in 1988, (with CDC as one of the 
four original spearheading partners along with 
WHO, UNICEF, and Rotary International ), the 
number of countries with endemic poliovirus 
transmission has decreased from 125 to 3, and 
reported polio cases have decreased from 
350,000 in 1988 to 650 in 2011.35
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support the development and introduction of new vaccines. CDC provides technical support to 
multiple global VPD surveillance and laboratory networks and conducts operational research to 
strengthen the quality and use of data from VPD surveillance systems. CDC actively supports 
introduction and evaluation of available and underused vaccines that have the potential to greatly 
reduce global VPD morbidity and mortality, such as Haemophilus influenzae type B, pneumococcal 
conjugate, rotavirus, human papillomavirus, meningococcal group A, hepatitis B vaccine 
administered within 24 hours of birth, rubella, seasonal influenza, Japanese encephalitis, typhoid, 
cholera, and yellow fever. CDC conducts research to develop or field test new vaccines to protect 
against leading killers (e.g., HIV, malaria, tuberculosis, rotavirus, and dengue) in developing 
countries.
CDC's efforts to strengthen immunization systems are implemented in the context of global health 
collaborations with other USG agencies and other partners such as WHO, UNICEF, Rotary 
International, the Bill and Melinda Gates Foundation, the GAVI Alliance, the American Red Cross, 
and the United Nations Foundation.
CDC Strategic Priorities
• Provide global leadership and expert technical assistance for VPD eradication/elimination 
initiatives and other targeted VPD control goals, with a particular focus on reaching the 
goals of the GPEI.
• Strengthen capacity and enhance performance of health systems to deliver routine 
immunization services on a sustained basis.
• Strengthen VPD health and information systems to enhance decision making capacity for 
immunization programs.
• Increase the appropriate development, introduction, and use of new and underused 
vaccines, such as pneumococcal and rotavirus vaccines, to prevent diseases of global and 
regional public health importance.
• Promote synergies between immunization and other public health interventions to 
strengthen health systems.
Objective 1.8: Reduce Burden of Non-Communicable Diseases
NCDs include chronic diseases (e.g., heart disease and stroke, cancer, diabetes), injuries, disabilities, 
and diseases caused by environmental hazards. NCDs kill more people globally than infectious 
diseases, affecting countries of all economic levels.39 Worldwide, the chronic illnesses of heart 
disease, stroke, cancer, and diabetes are responsible for 36 million deaths each year, representing 
nearly two-thirds of the world's total deaths.40 These four diseases share the common risk factors of 
tobacco use, unhealthy diets, physical inactivity, and harmful use of alcohol. Several are related to 
high blood pressure and high cholesterol. If not addressed, cumulative output loss is estimated to 
reach U.S. $47 trillion by 2030, threatening national and global economic advancement.40 In 
addition to chronic NCDs, injuries and environmental health hazards are also critical public health 
areas. Road traffic crashes are the leading cause of death worldwide for people between the ages of 
15 and 29.41 Injuries and violence are a major public health issue globally and account for nearly 1 
out of every 10 deaths every year.42 Lead poisoning is one of the m ost common and best-recognized
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childhood diseases of toxic environmental origin.43 Cooking and heating indoors using solid fuels 
pollutes the air and increases the risk of illness for nearly 3 billion people worldwide.44
CDC's global work addressing infectious diseases has helped build expertise and reliable service 
delivery platforms in many developing counties that can help reduce the burden of NCDs. 
Specifically, CDC's role in addressing NCDs focuses on (1) surveillance, epidemiology, and 
laboratory support; (2) identifying risk factors and evidence-based prevention strategies; (3) 
strengthening data, data systems, and use of data to increase effective policy development and 
public health action; and (4) increasing country capacity and workforce skill development.
CDC helped establish the Global Tobacco Surveillance System (GTSS), which aims to enhance 
country capacity to design, implement, and evaluate tobacco control interventions. CDC also 
collaborates with WHO to develop and disseminate guidelines for cervical cancer screening and 
helps build country capacity to conduct high-quality cervical cancer screening, surveillance, and 
prevention.
CDC works with a variety of global partners to 
build capacity by improving road traffic injury 
surveillance systems, documenting the 
magnitude and impact of traffic injuries, and 
developing and testing effective interventions.
To improve access to safe w ater and hygiene,
CDC helps to identify water, sanitation, and 
hygiene interventions, such as technology to 
trea t and safely store drinking w ater in homes.
In addition CDC assists in identifying hazards 
and solutions to contamination of community w ater sources.
CDC Strategic Priorities 
Chronic Diseases
• Assist countries to develop, implement, and evaluate national plans to address the burden 
of NCDs and their risk factors.
• Strengthen country capacity to conduct surveillance of chronic disease risk factors and use 
of data for guidance and decision-making.
• Help build the global evidence base for NCD prevention and control by supporting the 
implementation and evaluation of interventions.
• Assist countries to develop, implement, and evaluate the Global Adult Tobacco Survey 
(GATS), and use data to inform interventions in accordance with the Framework 
Convention on Tobacco Control and the MPOWER strategy.
• Assist and support countries to plan, implement, and evaluate activities to reduce sodium 
consumption and high blood pressure through guidelines, programs, and partnerships.
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CDC has provided technical assistance to 180 
countries on the implementation of globally 
standardized tobacco surveys for youth, 
adults, and specific population groups. The 
survey findings help countries track tobacco 
use and develop, implement, and evaluate 
tobacco control programs and policy 
interventions.
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Injuries and Violence
• Promote and implement international demonstration projects to prevent road traffic injury 
in worker populations, in support of high-priority activities for the UN Decade of Action for 
Road Safety.
• Enhance surveillance and evaluation of motorcycle helmet use globally and aid in the 
development of guidelines and programs which increase the use of helmets.
• Build country capacity in road safety injury surveillance and use of data for guidelines and 
decision-making, to support the successful implementation and evaluation of effective and 
appropriate interventions.
• Increase the capacity of low- and middle-income countries to measure the burden of 
violence through the implementation of national surveys designed to capture information 
on sexual, physical, and emotional violence to support the creation of guidelines.
Environmental Health Hazards
• Increase the number of lead-safe environments for children globally by providing technical 
support in the development and implementation of WHO guidelines for reduction of lead 
poisoning in children, elimination of lead paint globally, and remediation of contaminated 
sites.
• Improve water treatment, sanitation, and hygiene promotion (WaSH) programs, and 
enhance integration between WaSH programs and health services targeting vulnerable 
populations.
• Promote improved indoor air quality programs, and enhance their integration with health 
services, particularly for vulnerable populations.
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Goal 2: Health Security: Improve Capabilities to Prepare and 
Respond to Infectious Diseases, Other Emerging Health Threats, 
and Public Health Emergencies
The health of Americans is integrally connected to the health of the rest of the world. Governments 
and organizations m ust work to strengthen public health programs and increase the ability of 
countries to respond to and address disease threats on a global scale. Strengthening the health 
security of countries around the world contributes to healthy, stable, and productive societies. 
Improving global health also makes the United States more secure by building partnerships that can 
solve local problems before they become global challenges. CDC provides public health technical 
and policy support to USG security and development organizations involved in global health 
security activities worldwide. CDC's global health security activities are integral to the 
implementation of the National Security Strategy and the National Strategy for Countering 
Biological Threats which call on the U.S. Government to promote global health security, reinforce 
norms of safe and responsible conduct, and obtain timely and accurate insight on current and 
emerging risks: all CDC core areas of expertise. CDC works with other USG agencies to support 
national and international health and security strategic partnerships such as the Global Partnership 
Against the Spread of Weapons and Materials of Mass Destruction (G8GP), and assists other federal 
agencies and other governments m eet their responsibilities under the Biological Weapons 
Convention (BWC) and the U.N. Security Council Resolution (UNSCR) 1540.
Objective 2.1: Strengthen Capacity to Prepare for and Detect Infectious 
Diseases and Other Emerging Health Threats
In recent decades, the world has faced an accelerating assault from emerging infections, both from 
new diseases and changing endemic ones. HIV, West Nile virus, and SARS are examples of diseases 
caused by previously unknown or minor pathogens that have had global impact. Strong public 
health systems enable countries to quickly identify and effectively respond to these dynamic events. 
Pathogens ignore borders, and a problem at one locality can rapidly threaten the world. 
International standards have emphasized the importance of all countries to conduct surveillance 
where it was not previously done, such as at ports of entry, in refugee settings, and among migrant 
populations. CDC works to strengthen the preparedness of public health systems to detect and 
respond to emerging health threats. This entails not only supporting MOH infrastructure 
development, but also helping to build the human capacity to conduct surveillance, diagnose illness, 
communicate and analyze evidence, and respond effectively. In addition, CDC helps to build the 
capacity of other systems, such as enhancing surveillance in refugee camps to detect emerging 
disease threats. The 2005 International Health Regulations are an international legal instrum ent 
created by WHO and adopted by 194 countries with the aim to help prevent and respond to acute 
public health risks that have the potential to cross borders. CDC is a technical leader in IHR 
implementation, working with other agencies to build global capacity.
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CDC works with countries to identify potentially emerging pathogens, including pathogens causing 
respiratory, diarrheal, foodborne, 
zoonotic, and vectorborne infections.
Because an emerging pathogen is by its 
nature unknown or unanticipated, 
identifying pathogens requires the ability 
to do applied infectious disease research 
as well as integrated disease surveillance, 
laboratory diagnosis, prevention, and 
control. CDC has helped MOHs build 
laboratory diagnostic testing capacity in 
various countries (e.g., Uganda for 
diagnosing plague and hemorrhagic 
fevers). In countries served by Global 
Disease Detection Regional Centers, 
laboratory diagnostic testing capacity has 
not only assisted in overall rapid 
diagnosis of pathogens causing respiratory, diarrheal, foodborne, and vectorborne infections, but 
also with detection of new pathogens (Figure 3). CDC's strength and reputation as a global 
reference center is often critical to the identification of new threats. CDC has contacts in almost 
every country making timely response to outbreaks possible, often developing innovative, 
headquarters-based surveillance methods and new laboratory diagnostics to augment the detection 
and response. CDC works to strengthen refugee and migrant screening and treatm ent of infectious 
diseases, which improves the health of these populations and prevents the importation of diseases, 
such as multi-drug resistant TB.
CDC Strategic Priorities
• Increase country capacity to comply with the IHR by providing in-country support and 
technical assistance with planning efforts, including the development of plans for IHR 
implementation.
• Improve early detection for emerging threats through enhanced surveillance, 
communication, clinical diagnosis, event analysis, and response.
• Improve the capacity of laboratories to detect unusual pathogens by improving their 
capacity to accurately identify their endemic pathogens.
• Provide technical assistance and guidance to improve the detection of disease in vulnerable 
populations.
• Improve methods for detecting and preventing emerging pathogens that result from social 
and demographic trends that increase human contact with animals, vectors, and poor 
sanitation.
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Figure 3. By increasing the laboratory diagnostic testing capabilities in 
host and neighboring countries of the GDD Regional Centers, CDC has 
been able to detect new pathogens.
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Objective 2.2: Respond to International Public Health Emergencies and 
Improve Country Response Capabilities
When a humanitarian or natural emergency compromises health security or when global public 
health systems fail to detect a threat, it is vitally im portant tha t CDC work with international 
partners and MOHs to quickly respond to urgent needs. At the same time, the agency m ust also plan 
for long-term systems infrastructure support. In addition to large scale events, day-to-day efforts to 
control, manage, and trea t populations with certain 
diseases (e.g., multi-drug-resistant TB) are of critical 
importance. A delayed response can increase the 
magnitude of the problem and the challenges with 
containment. At the invitation of MOHs or WHO, CDC 
is able to quickly mobilize response units, comprised 
of a wide array of public health experts. When an 
emergency occurs, it is critical to respond early to 
control and reduce morbidity, mortality, and spread, 
and to help countries improve capabilities to prepare 
for future events following the response.
CDC engages its in-country, regional, and headquarters staff to rapidly respond to outbreaks in host 
countries for a wide range of emerging infections including respiratory syndromes, diarrheal 
diseases, foodborne illnesses, and zoonotic diseases. By establishing long-term relationships with 
MOHs and in-country partners, CDC assists countries to increase their capacity to respond to 
threats themselves. These relationships can reduce the time from recognition of a th reat or event to 
its containment and resolution. When a th reat or event requires CDC's rapid response, CDC deploys 
highly-skilled multidisciplinary teams. These teams draw upon a variety of public health 
professions from around the agency in areas such as epidemiology, laboratory, veterinary medicine, 
and risk communication to respond directly and assist country and regional offices in their 
responses to disease outbreaks. Deployments respond to known pathogens such as influenza, 
measles, polio, cholera, and anthrax, in addition to illnesses of unknown etiology, such as nodding 
disease. CDC implements laboratory networks and epidemiologic systems to track cases and 
prevent further spread of disease. CDC has responded to hundreds of outbreaks utilizing field 
offices and technical experts from headquarters.
In Haiti, CDC has developed a unique public health reconstruction portfolio focusing on seven 
health impact legacy goals to improve health and well-being. The first goal is an integrated public 
health system comprised of a tiered, public health workforce development program, a national 
reference laboratory referral network, and a robust reportable disease surveillance system. This 
integrated system has made it possible to set clear targets for three disease elimination goals and 
three disease burden goals tha t specifically address priorities outlined in the President's Global 
Health Initiative.
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Since 2006, CDC, in collaboration with 
MOHs, WHO, and other partners, has 
responded to over 900 international 
disease outbreaks and other public 
health emergencies. Of these, 64% 
were initiated within 24 hours of 
receiving a request for assistance and 
53% included laboratory support that 
led to a confirmed cause.
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CDC Strategic Priorities
• Control and reduce the spread of disease by conducting and supporting outbreak 
investigations at the invitation of the MOH or other partners.
• Facilitate rapid deployment of multidisciplinary CDC response teams to assist WHO and 
MOHs for outbreak responses.
• Build country emergency response capabilities to prepare and respond to disease threats by 
providing technical assistance and planning, including rapid response team development 
and coordination with the IHR National Focal Point.
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Goal 3: Health Capacity: Build Country Public Health Capacity
Building, strengthening, and maintaining countries' capacity to improve the health and well-being 
of their citizens is vital to development and stability, not only inside the borders of any one country, 
but regionally and globally. Health systems are networks of private and public sector organizations, 
working a t all levels of society to detect, control, prevent, and respond to the full spectrum of health 
threats. The public health system is an im portant component of the health system, serving as a 
partner in prevention, surveillance, policy, and response with hospital and clinic networks, and 
other sectors of society that impact overall health and disease prevention. Paramount to the long­
term  success of any health initiative is country ownership, and CDC is actively leveraging its 
technical expertise and country field offices to build this necessary capacity by responding to 
country and U.S. country mission priorities.
Objective 3.1: Strengthen Public Health Institutions and Infrastructure
CDC works to build and strengthen global public health capacity to achieve lasting health 
improvements. The agency seeks to help countries build capacity related to epidemiologic 
surveillance; laboratory, novel point-of-care and reference diagnostics; workforce; research; 
strategic information; expenditure and costing analyses; and outbreak response. A key method of 
strengthening this capacity is through CDC's work with WHO regional offices, MOHs, and National 
Public Health Institutes (NPHIs).45
MOHs are the entities that ultimately have the responsibility to conduct surveillance, respond to 
outbreaks, set national health policy guidelines, and report officially on behalf of the national 
government under the IHRs and other international treaties. A strong MOH is a very im portant 
contributor in achieving sustainable health programs, especially in low-resource settings.46 CDC 
provides technical leadership and training for leaders and staff at MOHs to build capacity within 
countries to better respond to future events. CDC supports the creation and expansion of laboratory 
systems and data management, and works with MOHs to expand their network a t the regional and 
national level building on CDC's expertise and experience in strengthening domestic 
infrastructures.
Investment in public health institutions can reduce morbidity and mortality and improve 
population health in resource-poor settings. In many countries, limited capacity to detect and 
respond to public health threats has ham pered progress toward improving health outcomes. 
Establishing or strengthening existing science-based NPHIs can provide expertise and leadership in 
core public health functions in low- and middle-income countries. A strong NPHI provides a single 
accountable agency, increases transparency, results in better surveillance for a more effective 
response to disease threats, and provides a home for building sustainable public health capacity. 
CDC relies upon public health professionals and subject m atter experts from across the agency and 
the ability to leverage existing partnerships with numerous collaborators to support building or 
strengthening NPHIs and other allied public health institutions. By linking NPHI efforts with the 
experts across CDC, disease-specific objectives are also addressed to maximize impact.
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CDC Strategic Priorities
• Improve public health outcomes through strengthened capacity and enhanced performance 
of public health programs and services at national and sub-national levels.
• Strengthen MOH infrastructure by enhancing its risk communication capabilities and its 
ability to communicate public health messages to health workers, the public, and the media.
• Lead the establishment of standards to define capacity development from a public health 
perspective.
• Provide technical assistance to countries in the establishment and strengthening of national 
public health institutes.
• Increase country ownership and sustainability by transitioning programmatic and financial 
responsibilities to host governments and local partners.
Objective 3.2: Improve Surveillance and Use of Strategic Information
CDC helps countries establish surveillance systems to produce reliable, timely information on 
health determinants, health status, and the performance of health systems. It also supports the 
development and implementation of complementary health information systems to support patient 
management and program monitoring. CDC strengthens the capacity of MOH officials to collect and 
analyze data from these multiple sources to make evidence-based public health decisions for 
impact. Improved surveillance methodologies and innovative technologies also provide countries 
with increased insight and flexibility to detect and respond more quickly and accurately.
Strategic epidemiologic information plays a critical central role in the effective functioning of health 
systems. CDC works with MOHs to build and enhance the systems needed to generate those data as 
well as supports the institutions responsible for managing those systems and interpreting the 
data. Advances in informatics benefit public health systems and have created unprecedented 
opportunities to transform public health practice through interoperable information systems that 
support surveillance, epidemiology, service implementation, and monitoring and evaluation. CDC 
provides coordination, leadership, and cross-cutting, comprehensive public health informatics 
strategies and standards to support information systems. The agency also supports the 
development of tools to strengthen public health systems and the practice of epidemiology, 
surveillance, laboratory, and patient management. The result of these activities leads to more 
accurate, timely, and complete information; improved analysis, reporting, and dissemination of 
data; and integrated information systems to extract and exchange data from various sources and 
systems. Through technical assistance and development of guidelines and tools, CDC works closely 
with MOHs to implement strategies and activities for improving surveillance and response.
Integrated Disease Surveillance and Response (IDSR) is a WHO/AFRO strategy adopted by the 46 
countries in the African region in 1998 for improving national surveillance and response systems. 
The goal of IDSR is to develop sufficient surveillance and response capacities at each level of the 
national system in order to detect and respond to those diseases tha t are priorities for African 
countries. CDC's role in IDSR has been to lead the design and development of the IDSR framework, 
building on components of polio, meningococcal meningitis, cholera, and yellow fever disease 
control programs. CDC provides surveillance and disease-specific expertise in designing and
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developing IDSR guidelines, surveillance norms, 
thresholds for action, standards, metrics, and 
implementation strategies. Because IDSR is 
grounded in activities for strengthening national, 
multi-level, multi-disease surveillance systems, 
the member countries recommended that the 
IHR be implemented through the IDSR 
framework and CDC has been working to include 
IHR requirements in materials and approaches.
Evidence of country ownership of IDSR is seen in assessm ent results. For example, by 2012, 43 of 
the 46 countries were implementing IDSR to some extent. At least half the countries have a national 
budget line for IDSR, have adopted regulations or legislation governing public health surveillance, 
and also have a national policy for IDSR implementation. Many countries are now publishing a 
weekly epidemiologic bulletin with analyzed data from reporting districts.48
CDC Strategic Priorities
• Assist countries in establishing health information systems that contribute to improved 
disease surveillance, patient management, program monitoring, and public health planning.
• Increase MOH ability to successfully manage the process of transforming data into 
knowledge, knowledge into guidelines, and guidelines into improved, cost-effective 
programs and public health practice.
• Assist countries in developing capacity for conducting critical surveillance activities such as 
monitoring disease burden, tracking morbidity and mortality data, evaluating behavioral 
risk factors, and monitoring and evaluating the impact of health interventions.
• Provide leadership in establishing consistent standards for global public health informatics.
Objective 3.3: Build Workforce Capacity
Effective public health systems depend on a trained and motivated workforce to carry out the 
services needed to achieve health goals. CDC's experts work with MOHs and other partners to 
establish a sustainable public sector health workforce globally. Establishing sustainable public 
health workforce capacity is more than just training—it requires strengthening a complex system 
of human resource dynamics, including planning and management of the health workforce; 
producing new health workers through pre-service education; ensuring adequate recruitm ent into 
the public health system; improving the quality of training, mentorship, and supervision; and 
providing appropriate retention incentives. CDC's highly trained medical officers, public health 
advisors, epidemiologists, health economists, behavioral scientists, laboratorians, veterinarians, 
and program managers offer unique technical and scientific expertise to strengthen sustainable 
public health workforce capacity.
Since 1980, CDC has worked in collaboration with local and international organizations to help 
MOHs develop Field Epidemiology Training Programs (FETPs), modeled after the U.S. Epidemic 
Intelligence Service, that build capacity in a range of areas, including epidemiology, laboratory 
sciences, outbreak investigation, health surveillance systems, applied research, program evaluation,
Evaluation of IDSR in Burkina Faso 
showed a two-week reduction in time to 
peak of meningitis outbreaks and 
statistically significant reductions in the 
number of cases and deaths, as well as a 
cost savings of $80 per case averted and 
$260 per death averted.47
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communications, and program management. CDC generally supports an FETP program for about 
five years, with gradual transfer of 
responsibility and program costs to ensure 
that the country can sustain the program. CDC 
also helps MOHs in developing countries to 
strengthen public health management 
policies, practices, and systems through 
competency building, strategic partnerships 
that leverage technical expertise, and applied 
research and evaluation.
CDC Strategic Priorities
• Improve workforce ability to conduct the core functions of public health, implement and 
manage critical health programs, and address country and regional priorities with a focus 
on strengthening existing and establishing new programs and networks (e.g., FETPs and 
FETP regional networks) by working with multi-national partners.
• Strengthen country public health workforce development planning by providing tools to 
conduct workforce assessments and to develop workforce plans based on assessment 
results.
• Improve leadership and management competencies a t MOHs and other public health 
institutions by developing and delivering training and by coordinating knowledge-sharing 
through established forums.
• Provide technical assistance in helping MOHs establish human resources information 
systems to track the production, registration, and deployment of the health workforce.
• Provide leadership to countries in developing workforce standards and policies and 
procedures to address topics such as retention, public health career paths, monitoring and 
measuring performance, and standard training curriculum to address workforce needs.
Objective 3.4: Strengthen Laboratory Systems and Networks
Laboratories play a vital role in the early detection and monitoring of a variety of diseases and 
health events, as well as in surveillance to 
monitor the impact of vaccination programs, 
enabling countries to better respond, treat, 
control, and prevent spread of disease in a 
population. Laboratories also play a critical 
role in monitoring and evaluation of the impact 
of program interventions to control and 
eliminate diseases. CDC assists countries to 
build sustainable and integrated laboratory 
networks as a critical and core component of 
the overall health system. CDC works to assist multiple countries in Africa, Asia, and Latin America 
to develop national strategic plans to strengthen public health laboratory networks. Key 
components addressed in these plans include: training and personnel retention, logistics and
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Since 2010, CDC has assisted 31 countries to 
implement a step-wise approach to improve 
laboratory quality management towards 
internationally recognized accreditation. This 
has resulted in provision of more reliable 
laboratory results for patient management, 
surveillance, and program monitoring and 
evaluation.
Since 1980, CDC has helped develop 46 
international Field Epidemiology Training 
Programs serving 64 countries, graduating 
over 2500 epidemiologists prepared to 
evaluate health programs and detect and 
respond to health threats.
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commodities management, facility and equipment maintenance, laboratory information systems, 
laboratory policy and regulatory issues, and improved quality management across national 
laboratory systems. These plans help to integrate parallel disease-specific laboratory systems 
where possible, building efficiency and strengthening the ability of countries to respond effectively 
to numerous infectious diseases, including HIV/AIDS, TB, malaria, emerging infections, and avian 
influenza. In addition to this im portant work in infectious diseases, laboratory systems are critical 
for early diagnosis, treatment, and interventions for non-communicable diseases.
CDC collaborates with USG partners, host governments, MOHs, non-governmental organizations, 
U.S.-based universities, multilateral organizations, and the private sector to provide systematic 
training, guidance, and support for laboratories. CDC works with international accrediting 
organizations to establish guidance for laboratory quality improvement towards accreditation of 
laboratory services in resource-constrained settings. In addition, CDC serves as a global reference 
laboratory in many disease-specific areas responding to global public health emergencies such as 
the H1N1 influenza pandemic and participating in global surveillance activities and international 
outbreak investigations.
CDC Strategic Priorities
• Support the development of laboratory-related policies, laws, standards, and national 
laboratory strategic plans to facilitate country ownership.
• Improve development of the laboratory workforce by conducting training and work with 
countries to create career paths and job descriptions and develop credentialing programs.
• Improve laboratory capacity by facilitating the development and maintenance of laboratory 
networks, improving laboratory biosafety, strengthening laboratory-based surveillance 
systems, developing and establishing specific diagnostic assays, and defining a minimum set 
of essential capabilities.
• Maximize resource use and public health response capability by integrating laboratory- 
based surveillance into comprehensive public health surveillance efforts.
• Strengthen laboratory quality management systems to enhance performance of individual 
laboratories and national laboratory networks, leading towards achievement of 
internationally recognized accreditation standards.
Objective 3.5: Improve Research Capacity
The primary objective of research for public health is to provide sound scientific evidence to 
develop tools and strategies to improve public health impact and public health systems, and to 
inform and improve relevant policy and guidelines. Research is also needed to assist in 
development of priorities with a focus on cost-effectiveness.
CDC conducts epidemiologic and laboratory research to improve existing or develop new promising 
interventions and tools, while examining the cost-effectiveness and efficiency of programs. Through 
its focus on research, CDC also works with partners to strengthen the capacity of Institutional 
Review Boards in countries to achieve improved guidance and safeguards for research activities.
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CDC also conducts public health systems research to examine the organization, financing, and 
delivery of public health services within communities and the impact of these services on public 
health. This concept can encompass broad aspects of translational, implementation, and operational 
research in order to achieve effective health outcomes.
CDC Strategic Priorities
• Identify new and strengthen existing public health interventions and validate the 
effectiveness of interventions and tools.
• Assist countries to develop expertise and capacity to conduct research (operational, applied, 
and laboratory) activities.
• Develop and disseminate guidelines to translate research into national initiatives for 
implementation to improve health activities.
• Develop, evaluate, and deploy innovative technologies to support epidemiologic and 
laboratory public health programs and global health security initiatives, with a particular 
focus on field and low-resource settings.
• Collaborate with host countries and USG partners to strengthen the capacity of local 
Institutional Review Boards.
Centers for Disease Control and Prevention
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Goal 4: Organizational Capacity: Maximize Potential of CDC's 
Global Programs to Achieve Impact
To maximize impact, CDC m ust function in an integrated way, delivering public health programs 
and conducting research supervised directly by the responsible CDC program for technical 
excellence and accountability, but also 
integrating across multiple programs for 
synergy, efficiency and coordination. In 
addition, CDC coordinates with multiple USG 
agencies and multilateral and bilateral partners 
to ensure an integrated, comprehensive 
approach to global health. Further, CGH 
provides management and operational support 
to CDC's field staff and offices where global 
health activities are implemented in order to improve efficiency and enhance communication and 
coordination.
Objective 4.1: Strengthen Organizational and Technical Capacity to 
Better Support CDC's Global Health Activities
Fundamental to strong, sustained program implementation is an efficient organizational capacity to 
support those efforts. CGH, in close coordination with other CDC global programs and CDC business 
services offices, provides management and operational support to CDC country operations and field 
offices in a variety of areas, including country governance, overseas operations, and workforce 
planning and management.
Consistency in country operations is an im portant aspect of organizational capacity. CDC has 
established a governance structure for country operations which clearly defines the roles and 
responsibilities of headquarters and field offices. CDC has also developed a w ritten guide to global 
operations that provides agreed-upon tools, guidance, and procedures to promote consistency and 
accountability. CDC m ust continue to recruit and prepare staff for international assignments and 
recruit, train, retain, and provide professional development for talented locally employed staff to 
deliver and support country work.
CDC Strategic Priorities
• Improve and continuously modify as needed the implementation of the country governance 
structure by systematically collecting and evaluating feedback to ensure the structure is 
meeting the needs of the country field offices.
• Improve efficiency, consistency, and accountability of headquarters and overseas office 
operations by providing guidance on strengthening infrastructure and management 
systems.
CDC's work overseas is affected by many 
U.S. Government laws and regulations, 
and HHS policies. In early 2012, CDC 
released an electronic, updated CDC 
Guide to Global Operations, which 
provides overseas staff easy, user-friendly 
access to this information.
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• Improve workforce planning, processes, and support to consistently address recruitment, 
retention, and training needs to build and sustain a capable workforce.
• Increase the skills of CDC's technical experts to address evolving global health priorities and 
to help build country capacity.
Objective 4.2 Enhance Communication to Expand the Impact of CDC's 
Global Health Expertise
Critical to CDC's ability to maximize the impact of global programs are improvements in 
communication and coordination among CDC's headquarters programs and field offices and with its 
partners. CDC develops evidence for effective public health interventions, and the impact of its 
global health work is amplified when knowledge about the relative impact and cost-effectiveness of 
those interventions is effectively communicated:
• Within CDC, across programs and countries, and between headquarters and the field.
• With other USG departments and agencies to assure a whole-of-government approach.
• With multilateral institutions which establish guidelines and /or invest in global health 
programs.
• With other donor nations investing in global health programs.
• With implementing partners, including most importantly officials in host ministries.
• With policymakers to inform decisions about investments of scarce resources.
• With the policy and academic community to perm it even greater refinement and 
amplification of scientific findings.
• With a broad array of media to reach multiple audiences and thus better communicate the 
full extent of USG contributions.
Each audience demands a different communication and dissemination approach. CDC will intensify 
efforts to communicate and disseminate key public health information.
CDC Strategic Priorities
• Work strategically across the agency to improve effectiveness of programs and improve 
coordination and integration of global health efforts.
• Articulate CDC's unique role in global health to create awareness of the importance of cost 
effective evidence-based programming among partners and stakeholders.
• Increase the partnership capacity of CDC's global health programs by supporting and 
facilitating partnership outreach and communication to existing and new partners.
• Improve and encourage communication across CDC programs (headquarters and field) to 
more effectively utilize and maximize resources and knowledge.
Centers for Disease Control and Prevention
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Conclusion
CDC's Global Health Strategy outlines the agency's approach to achieving its global health vision of a 
healthier and safer world, and protecting the US from external health threats, through programs 
based on strong scientific evidence. The strategy will be integrated into planning, decision-making, 
and the implementation and evaluation of CDC's global health activities. This includes prioritizing 
activities and partnerships and leveraging resources, investments, and the work of other USG and 
global partners, with an overriding focus on improving coordination and communication to 
maximize impact.
CDC looks forward to working with its partners across the U.S. Government, international 
organizations, and MOHs in partner countries as all continue to strive for lasting impact in global 
health.
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• 2008-2013 Action Plan fo r  Global Strategy fo r  the Prevention and Control o f Non- 
communicable Diseases, April 2008. World Health Organization 
http://w w w .w ho.int/nm h/publications/ncd action plan en.pdf
• A CDC Framework fo r  Preventing Infectious Diseases: Sustaining the Essentials and Innovating 
fo r  the Future, October 2011. U.S. Department o f Health and Human Services, Centers fo r  
Disease Control and Prevention 
http://www.cdc.gov/oid/docs/ID-Framework.pdf
• A National Strategic Plan for Public Health Preparedness and Response, September 2011. 
U.S. Department of Health and Human Services, Centers for Disease Control and 
Prevention, Office of Preparedness and Response
http://w w w .cdc.gov/phpr/publications/2011M  Natl Strategic Plan for Preparedness 2 
0110901A.pdf
• Association o f Public Health Laboratories Strategic Plan 2010-2013 
http://www.aphl.org/AboutAPHL/publications/Documents/APHL Strategic Plan 2010- 
2013.pdf
• The Biological Weapons Convention, United Nations Office 
http://www.unog.ch/80256EE600585943/(httpPages)/04FBBDD6315AC720C1257180004B1B 
2F?OpenDocument
• CDC Global Immunization Strategic Framework, 2011-2015. U.S. Department of Health and 
Human Services, Centers for Disease Control and Prevention 
http://www.cdc.gov/ncird/downloads/GID-strat-framewk.pdf
• CDC's Public Health Framework fo r  Health Systems Strengthening. U.S. Department of 
Health and Human Services, Centers for Disease Control and Prevention 
http://www.cdc.gov/globalhealth/pdf/HHS one pager factsheet press quality.pdf
• Diarrhoea: why children are still dying and what can be done. World Health Organization, 
United Nations Children's Fund
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Appendix: Global Health Strategies, Frameworks, and Plans
• The First Quadrennial Diplomacy and Development Report: Leading Through Civilian 
Power, 2010. U.S. Department o f State 
h ttp ://w w w .state .gov /s/dm r/qddr/
• Global Action Plan fo r  the Prevention and Control o f Pneumonia, World Health 
Organization, United Nations Children's Fund 
http://www.unicef.org/media/files/GAPP3 web.pdf
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• Global Alliance fo r  Clean Cookstoves 
http://cleancookstoves.org/
• Global Health Strategic Framework: Better Health for Development FY 2012 -  FY 2016.
April 2012, U.S. Agency for International Development
http://transition.usaid.gov/our work/global health/hom e/Publications/gh framework.h 
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• Global Health Strategy, 2011-2015. U.S. Department o f Health and Human Services 
http://globalhealth.gov/pdfs/GlobalHealthSecretary.pdf
• Global Malaria Action Plan, Roll Back Malaria 
http://www.rollbackmalaria.org/rbmgmap.html
• Global Measles and Rubella Strategic Plan, 2012-2020. World Health Organization 
http://www.w ho.int/im m unization/new sroom /M easles Rubella StrategicPlan 2012 20 
20.pdf




• The Global Plan to Stop TB, 2011-2015: Transforming the Fight Towards Elimination o f 
Tuberculosis, October 2010. World Health Organization, STOP TB Partnership 
http://stoptb.org/assets/docum ents/global/plan/TB  GlobalPlanToStopTB2011- 
2015.pdf
• Global Polio Emergency Action Plan, 2012-13 
http://w w w .w ho.int/im m unization/new sroom /highlights/2011/en/index3.htm l 
http://timesofindia.indiatimes.com/topic/20.-Global-Polio-Emergency-Action-Plan- 
2012-13
• Global Tuberculosis Control, 2011. World Health Organization 
http://w w w .w ho.int/tb/publications/global report/en/index.htm l
• Governance Document fo r Country Offices and Global Operations, January 2011.
Department of Health and Human Services, Centers for Disease Control and Prevention, 
Center for Global Health
• Guidance fo r  Global Health Initiative Country Strategies, February, 2011. Department of 
Health and Human Services, Centers for Disease Control and Prevention, Center for Global 
Health, Global Health Initiative
http://www.ghi.gov/docum ents/organization/165092.pdf
• International Health Regulations, 2005 (reprinted in 2008). World Health Organization 
h ttp ://w w w .w ho.in t/ihr/en /
• Lantos-Hyde United States Government Malaria Strategy, 2009-2014 
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• The Millennium Development Goals, United Nations Development Programme 
http://w eb.undp.org/m dg/basics.shtm l
• The Millennium Development Goals Report, 2011. United Nations Secretary-General 
http://www.un.org/millenniumgoals/11 MDG%20Report EN.pdf
• MPOWER Measures, World Health Organization 
http://w w w .w ho.int/tobacco/m pow er/en/
• National Security Strategy, 2010. The White House 
http://w w w .w hitehouse.gov/sites/default/files/rss viewer/national security strategy.p
df
• President's Malaria Initiative 
http://www.fightingmalaria.gov/
• The President's Malaria Initiative Sixth Annual Report to Congress, April 2012. U.S. Agency 
for International Development
http ://pm i.gov/resources/reports/pm i annual report12.pdf
• President's Emergency Plan for AIDS Relief 
http: //www.pepfar.gov/
• President's Emergency Plan for AIDS Relief: Five-Year Strategy, December 2009 
http://ww w .pepfar.gov/strategy/docum ent/133251.htm
• UN Decade o f Action for Road Safety. Peden M. UN General Assembly calls fo r  decade o f 
action for road safety. Injury Prevention. 2010; 16(3):213. 
http://www.roadsafetyfund.org/UnDecadeOfAction/Pages/default.aspx
• UN Security Council Resolution (UNSCR) 1540, U.S. Department of State 
http://w w w .state.gov/t/isn/c18943.htm
• U.S. Government Global Health Initiative Strategy, March 2011. U.S. Global Health Initiative 
http://ww w .ghi.gov/resources/strategies/159150.htm
• U.S. Global Health Initiative 
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• World Malaria Report, 2011. World Health Organization 
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• Winnable Battle Plan: Global Immunization. U.S. Department of Health and Human 
Services, Centers for Disease Control and Prevention 
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• Winnable Battle Plan: Global Motor Vehicles. U.S. Department of Health and Human 
Services, Centers for Disease Control and Prevention 
http://www.cdc.gov/W innableBattles/MotorVehicleInjury/index.html
• Winnable Battle Plan: Lymphatic Filariasis. U.S. Department of Health and Human 
Services, Centers for Disease Control and Prevention 
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• Winnable Battle Plan: Mother-to-Child Transmission o f HIV and Syphilis Globally. U.S. 
Department of Health and Human Services, Centers for Disease Control and Prevention 
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Centers for Disease Control and Prevention 
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